BBOTVSNFE• 12 Months (Normalized)
BBOT vs NFE (BridgeBio Oncology Therapeutics Inc. vs New Fortress Energy Inc.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-68.73%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
NFE Performance $6.57
+205.58%
New Fortress Energy Inc.
Normalized Baseline0.00%
Alpha Spread Margin NFE LEADS
-274.31 pts
NFE outperforming by 274.31 percentage points
BBOTNFE
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT NFE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | BBOT Price | BBOT Gain (%) | NFE Price | NFE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -68.73% | $6.57 | +205.58% | -274.31% |
| Oct 01, 2026 | $- | $5.91 | +174.88% | - | |
| Sep 30, 2026 | $4.10 | -67.04% | $6.27 | +191.63% | -258.67% |
| Sep 29, 2026 | $3.92 | -68.49% | $6.08 | +182.79% | -251.28% |
| Sep 28, 2026 | $3.81 | -69.37% | $6.48 | +201.40% | -270.77% |
| Sep 25, 2026 | $3.95 | -68.25% | $- | - | |
| Sep 24, 2026 | $3.99 | -67.93% | $- | - | |
| Sep 23, 2026 | $4.16 | -66.56% | $6.40 | +197.67% | -264.23% |
| Sep 22, 2026 | $4.66 | -62.54% | $8.15 | +279.07% | -341.61% |
| Sep 21, 2026 | $4.66 | -62.54% | $10.82 | +403.26% | -465.80% |
| Sep 18, 2026 | $4.77 | -61.66% | $12.22 | +468.37% | -530.03% |
| Sep 17, 2026 | $4.89 | -60.69% | $12.41 | +477.21% | -537.90% |
| Sep 16, 2026 | $4.76 | -61.74% | $12.51 | +481.86% | -543.60% |
| Sep 15, 2026 | $4.88 | -60.77% | $12.77 | +493.95% | -554.72% |
| Sep 14, 2026 | $5.05 | -59.41% | $13.88 | +545.58% | -604.99% |
Page 1 of 17